Support Care Cancer. 2021 Oct;29(10):5557-5558. doi: 10.1007/s00520-021-06389-1. Epub 2021 Jun 26.

Acute renal injury after high-dose methotrexate is independent of folinic acid dose.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Ian J Cohen

PMID: 34176019 DOI: 10.1007/s00520-021-06389-1

[No abstract available.]

References

1. Cohen IJ, Vogel R, Matz S, Weitz R, Mor C, Stern S, Zaizov R (1986) Successful non-neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine, and BCNU protocol (DEMOB). Cancer 57:6–11 - PubMed
2. Cohen IJ (2018) The importance of adequate methotrexate and adequate folinic acid rescue doses in the treatment of primary brain lymphoma. J Neurooncol 140:757–757 - PubMed
3. Barrento JN, Peterson KT, Barreto ER, Mara KC, Dierkhising RA, Leung N, Witzig TE, Thompson CA (2021) Early empiric high dose leucovorin rescue in lymphoma patients treated with sequential doses of high-dose methotrexate. Support Care Cancer. https://doi.org/10.1007/s00520-021-06106-y - PubMed
4. Cohen IJ (2009) High-dose methotrexate is effective in osteosarcoma so what is the problem? J Pediatr Hematol Oncol 31:892–894 - PubMed
5. Shkalim-Zemer V, Ash S, Toledano H, Kollender Y, Issakov J, Cohen IJ (2015) Highly effective reduced toxicity dose - intensive pilot protocol for non-metastatic limb osteosarcoma (SCOS89). Cancer Chemother Pharmocol 76:909–916 - PubMed

Publication Types

• Letter